Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,081 | -25,147 | -12,369 | -1,728 | -17,521 |
| Depreciation Amortization | 1,943 | 1,344 | 207 | 35 | 141 |
| Accounts receivable | -388 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,104 | -86 | -3,003 | -815 | -255 |
| Other Operating Activity | 17,709 | 13,095 | 6,665 | -689 | 3,370 |
| Operating Cash Flow | $-13,713 | $-10,794 | $-8,499 | $-3,197 | $-14,265 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 462 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -252 | -415 | -363 | -3,111 |
| Net Acquisitions | 2 | 2 | 2 | N/A | 1,575 |
| Purchase Sale Intangibles | -293 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -695 | -32 | 0 | 0 | -6,172 |
| Investing Cash Flow | $-231 | $-282 | $-414 | $-363 | $-7,708 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,054 | 558 | 471 | 346 | N/A |
| Other Financing Activity | -42 | 0 | 0 | 183 | 34,622 |
| Financing Cash Flow | $4,012 | $558 | $471 | $529 | $34,622 |
| Beginning Cash Position | 15,900 | 16,012 | 15,803 | 15,900 | 3,657 |
| End Cash Position | 5,968 | 5,494 | 7,360 | 12,869 | 16,306 |
| Net Cash Flow | $-9,932 | $-10,518 | $-8,442 | $-3,031 | $12,649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,713 | -10,794 | -8,499 | -3,197 | -14,265 |
| Capital Expenditure | N/A | -252 | -415 | -363 | N/A |
| Free Cash Flow | -13,713 | -11,046 | -8,915 | -3,560 | -14,265 |